Inhibition of cytotoxic responses by prostaglandin E2 in the presence of interleukin 2.
D000818:Animals; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D015232:Dinoprostone; D004306:Dose-Response Relationship, Immunologic; D007165:Immunosuppression Therapy; D007213:Indomethacin / Q000494:pharmacology; D007376:Interleukin-2 / Q000096:biosynthesis / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D011458:Prostaglandins E / Q000494:pharmacology*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D014301:Trinitrobenzenes / Q000276:immunology
D007376:Interleukin-2; D011458:Prostaglandins E; D014301:Trinitrobenzenes; D015232:Dinoprostone; D007213:Indomethacin